562792-68-1 Usage
Description
6-(PYRIDIN-4-YL)IMIDAZO[2,1-B]THIAZOLE-5-CARBALDEHYDE is a complex chemical compound characterized by a pyridin-4-yl group attached to an imidazo[2,1-b]thiazole ring, featuring a carbaldehyde functional group at the 5 position of the thiazole ring. This unique molecular structure endows it with potential applications in medicinal chemistry and drug development, making it a compound of interest for further research and development due to its possible interactions with biological systems.
Uses
Used in Medicinal Chemistry:
6-(PYRIDIN-4-YL)IMIDAZO[2,1-B]THIAZOLE-5-CARBALDEHYDE is used as a key intermediate in the synthesis of various pharmaceutical agents for its potential to contribute to the development of new drugs.
Used in Drug Development:
In the pharmaceutical industry, 6-(PYRIDIN-4-YL)IMIDAZO[2,1-B]THIAZOLE-5-CARBALDEHYDE is utilized as a building block for designing novel therapeutic agents, potentially targeting a range of diseases and conditions.
Used in Biological Research:
6-(PYRIDIN-4-YL)IMIDAZO[2,1-B]THIAZOLE-5-CARBALDEHYDE serves as a valuable tool in biological research, aiding scientists in understanding the interactions between this compound and various biological systems, which could lead to the discovery of new mechanisms of action or therapeutic targets.
Check Digit Verification of cas no
The CAS Registry Mumber 562792-68-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,6,2,7,9 and 2 respectively; the second part has 2 digits, 6 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 562792-68:
(8*5)+(7*6)+(6*2)+(5*7)+(4*9)+(3*2)+(2*6)+(1*8)=191
191 % 10 = 1
So 562792-68-1 is a valid CAS Registry Number.
InChI:InChI=1/C11H7N3OS/c15-7-9-10(8-1-3-12-4-2-8)13-11-14(9)5-6-16-11/h1-7H
562792-68-1Relevant articles and documents
Synthesis and antitumor activity of guanylhydrazones from 6-(2,4-dichloro-5-nitrophenyl)imidazo[2,1-b]thiazoles and 6-pyridylimidazo[2,1- b]thiazoles
Andreani, Aldo,Burnelli, Silvia,Granaiola, Massimiliano,Leoni, Alberto,Locatelli, Alessandra,Morigi, Rita,Rambaldi, Mirella,Varoli, Lucilla,Farruggia, Giovanna,Stefanelli, Claudio,Masotti, Lanfranco,Kunkel, Mark W.
, p. 7897 - 7901 (2007/10/03)
The design and synthesis of antitumor imidazothiazole guanylhydrazones are reported. The compounds were submitted to NCI for testing. All but one were more active than methyl-GAG. A few compounds were selected for further studies in search of a possible mechanism of action. The results from these studies and a final search with the NCI COMPARE algorithm suggest that the guanylhydrazones described in this paper are acting through a novel mechanism of action.
